altogether better

Integrated research compliance solutions to streamline your study

Get a Quote

Thank You Sites!

We are grateful for the work you do every day to improve human health.
Read More | Free eLearning

Upcoming Virtual Symposium

Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research 
Register Now

Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.

Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.

Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more

Our Latest Updates

Discover What’s Happening at Advarra


IRB Advisor Features Advarra Executive James Riddle in Article About Research Post-COVID-19

May 28, 2020

IRB Advisor interviewed James Riddle, Advarra VP of Institutional Services, for its article “What Happens to Human Research in the...


sIRB 101: An Introduction to Relying on an External IRB

Federal mandates for single IRB (sIRB) review of multisite research have ushered in a new era of sIRB oversight. Multisite research funded by NIH, HHS, and other agencies must now…


Safety Precautions for Laboratory Research With COVID-19 Specimens

May 27, 2020

The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized to the proposed research as well as the existing facility and local regulatory requirements.

Ready for Research Compliance Solutions That Are Altogether Better?

Get Started